FOXM1 and cancer: Collectively, homologous receptor binding studies suggest that WIN-55,212-2 binds to a single site with similar high affinity for non-canonical CBRs differentially expressed in all cancer cell lines examined, although with slightly lower affinity than for canonical CB1Rs in mouse brain.